This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Adachi, R. Articles by Makishima, M. Search for Related Content PubMed PubMed Citation Articles by Adachi, R. Articles by Makishima, M.

Structural Determinants for Vitamin D Receptor Response to Endocrine and Xenobiotic Signals

Graduate Schools of Medicine (R.A., I.S., M.M.) and Frontier Biosciences (I.S., M.M.), Osaka University, Osaka 565-0871, Japan; Howard Hughes Medical Institute and Department of Pharmacology (A.I.S., D.J.M.), University of Texas Southwestern Medical Center, Dallas, Texas 75390-9050; Institute of Biomaterials and Bioengineering and School of Biomedical Science (K.Y., S.Y.), Tokyo Medical and Dental University, Tokyo 101-0062, Japan

Address all correspondence and requests for reprints to: Makoto Makishima, Graduate School of Frontier Biosciences, Osaka University, 2–2 Yamadaoka, H2, Suita, Osaka 565-0871, Japan. E-mail: maxima{at}fbs.osaka-u.ac.jp.

The vitamin D receptor (VDR), initially identified as a nuclear receptor for 1,25-dihydroxyvitamin D₃ [1,25(OH)₂D₃], regulates calcium metabolism, cellular proliferation and differentiation, immune responses, and other physiological processes. Recently, secondary bile acids such as lithocholic acid (LCA) were identified as endogenous VDR agonists. To identify structural determinants required for VDR activation by 1,25(OH)₂D₃ and LCA, we generated VDR mutants predicted to modulate ligand response based on sequence homology to pregnane X receptor, another bile acid-responsive nuclear receptor. In both vitamin D response element activation and mammalian two-hybrid assays, we found that VDR-S278V is activated by 1,25(OH)₂D₃ but not by LCA, whereas VDR-S237M can respond to LCA but not to 1,25(OH)₂D₃. Competitive ligand binding analysis reveals that LCA, but not 1,25(OH)₂D₃, effectively binds to VDR-S237M and both 1,25(OH)₂D₃ and LCA bind to VDR-S278V. We propose a docking model for LCA binding to VDR that is supported by mutagenesis data. Comparative analysis of the VDR-LCA and VDR-1,25(OH)₂D₃ structure-activity relationships should be useful in the development of bile acid-derived synthetic VDR ligands that selectively target VDR function in cancer and immune disorders without inducing adverse hypercalcemic effects.

NURSA Molecule Pages Link:

Nuclear Receptors:   VDR  |  PXR

Coregulators:   SRC-1  |  NCOR

Ligands:   Calcitriol

This article has been cited by other articles:

				E. J. Reschly, N. Ai, S. Ekins, W. J. Welsh, L. R. Hagey, A. F. Hofmann, and M. D. Krasowski Evolution of the bile salt nuclear receptor FXR in vertebrates J. Lipid Res., July 1, 2008; 49(7): 1577 - 1587. [Abstract] [Full Text] [PDF]

				Y. Inaba, K. Yamamoto, N. Yoshimoto, M. Matsunawa, S. Uno, S. Yamada, and M. Makishima Vitamin D3 Derivatives with Adamantane or Lactone Ring Side Chains are Cell Type-Selective Vitamin D Receptor Modulators Mol. Pharmacol., May 1, 2007; 71(5): 1298 - 1311. [Abstract] [Full Text] [PDF]

				S. Fukuen, M. Iwaki, A. Yasui, M. Makishima, M. Matsuda, and I. Shimomura Sulfonylurea Agents Exhibit Peroxisome Proliferator-activated Receptor {gamma} Agonistic Activity J. Biol. Chem., June 24, 2005; 280(25): 23653 - 23659. [Abstract] [Full Text] [PDF]

				J. Jyrkkarinne, B. Windshugel, J. Makinen, M. Ylisirnio, M. Perakyla, A. Poso, W. Sippl, and P. Honkakoski Amino Acids Important for Ligand Specificity of the Human Constitutive Androstane Receptor J. Biol. Chem., February 18, 2005; 280(7): 5960 - 5971. [Abstract] [Full Text] [PDF]

				R. Adachi, Y. Honma, H. Masuno, K. Kawana, I. Shimomura, S. Yamada, and M. Makishima Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative J. Lipid Res., January 1, 2005; 46(1): 46 - 57. [Abstract] [Full Text] [PDF]